Deal of the Day — today's pharmacy picks
Bortrac 2mg Injection

Bortrac 2mg Injection

Prescription requiredRx Required

Salt Composition: Bortezomib

Expiry Date: 01/2028

Special offer

Enquire

Inclusive of all taxes

▼

1 Injection

About The Product

  • ​Multiple myeloma
  • Mantle-cell lymphoma

Bortrac 2mg Injection is a targeted therapy-based anticancer medicine. It is prescribed to treat multiple myeloma and mantle-cell lymphoma in adult patients. The generic name of this medication is Bortezomib, and it is a novel proteasome inhibitor. It is commonly used in patients who have had two unsuccessful previous therapies. It is injected intravenously by a doctor or a trained nurse only.

Side Effects of Bortrac 2mg Injection

Side effects are undesirable symptoms that can result from any medical treatment. Like any other medicine, Bortrac 2mg Injection also causes some adverse impact on the body, most of which resolves without any medical attention.
Some common side effects include:

  • Constipation
  • Nausea
  • Loss of appetite
  • Stomach pain
  • Redness and swelling at the injection site
  • Dizziness
  • Tingling in hands and arms
  • Sore throat
  • Shortness of breath
  • Increased bleeding
  • Fever
  • Chills
  • Wheezing
  • Muscle cramps
  • Fatigue
  • Fever
  • Anemia
  • Neutropenia
  • Thrombocytopenia
  • Numbness
  • Rash



How To Use

  • Bortrac 2mg Injection is given by a doctor or trained nurse under strict medical supervision.
  • It is not self-administerable.
  • The dosage and duration of the treatment are determined by the doctor based on the patient's health condition.

How It Works

Bortrac 2mg Injection is an anticancer medicine that belongs to the class of proteasome inhibitors. It works by blocking or slowing down the breakdown of protein (26S proteasome) in cells.

It leads to the accumulation of protein in cancer cells, which ultimately causes cell death.

Safety Advice

Alcohol
Avoid the consumption of alcohol while taking Bortrac 2mg Injection, as alcohol can reduce the effectiveness of the medicine and worsen the symptoms
Pregnancy
Bortrac 2mg Injection is not recommended during pregnancy as it is unsafe for the developing fetus. Doctors rarely prescribe this medicine in pregnancy.
Breast Feeding
Bortrac 2mg Injection is unsafe to use during breastfeeding as it may cause toxicity to the baby.
Driving
Bortrac 2mg Injection may cause side effects such as dizziness or lack of concentration, which could affect your ability to drive. So it's better to avoid driving or operating heavy machinery.
Kidney
Consumption of Bortrac 2mg Injection should be avoided without informing the doctor if you have any kidney-related issues.
Liver
Consumption of Bortrac 2mg Injection tablet should be avoided without informing the doctor if you have any liver-related issues.

Missed Doses

It is not advisable to miss any dose of Bortrac 2 but in case you miss a dose, consult your doctor immediately.

FAQs

Bortrac 2mg injection is an anticancer injection that is primarily used in the treatment of multiple myeloma and mantle-cell lymphoma.

Reference

1. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215331s000lbl.pdf 2. Roccaro, A.

M., Vacca, A., & Ribatti, D. (2006).

Bortezomib in the treatment of cancer. Recent patents on anti-cancer drug discovery, 1(3), 397-403- https://pubmed.ncbi.nlm.nih.gov/18221049/ 3.

Kouroukis, T. C., Baldassarre, F.

G., Haynes, A. E., Imrie, K., Reece, D.

E., & Cheung, M. C.

(2014). Bortezomib in multiple myeloma: systematic review and clinical considerations.

Current oncology, 21(4), e573 - https://pubmed.ncbi.nlm.nih.gov/25089109/ 4. Mujtaba, T., & Dou, Q.

P. (2011).

Advances in the understanding of mechanisms and therapeutic use of bortezomib. Discovery medicine, 12(67), 471.

5. Jackson, G., Einsele, H., Moreau, P., & San Miguel, J.

(2005). Bortezomib, a novel proteasome inhibitor, in the treatment of hematologic malignancies.

Cancer treatment reviews, 31(8), 591-602 - https://pubmed.ncbi.nlm.nih.gov/16298074/

Certified Content

Written By
Venika Choudhary

Venika Choudhary

Medical Content Writer @ Magicine Pharma

Reviewed By
Dr. Aditya Sarin

Dr. Aditya Sarin

MBBS, MD - General Medicine, DrNB - Medical Oncology | 11 Years Experience

Check Our Editorial Policy

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Read full medical disclaimer in Terms & Conditions
Magicine PharmacopyCopyright 2026